News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Thor Halfdanarson: Consensus Guidelines for the Management of Peritoneal Surface Malignancies
Thor Halfdanarson/mayoclinic.org
Jun 27, 2025, 07:44

Thor Halfdanarson: Consensus Guidelines for the Management of Peritoneal Surface Malignancies

Thor Halfdanarson, Medical Oncologist at the Mayo Clinic, shared a post on X:

“Interested in the multidisciplinary management of peritoneal malignancies…? If so, I have the reading materials for you.
Check out the Consensus Guidelines for the Management of Peritoneal Surface Malignancies out today!
Lots of goodies there…”

More posts featuring Thor Halfdanarson on OncoDaily.

cancer OncoDaily Oncology Peritoneal Surface Malignancies. Thor Halfdanarson
Special Coverage
Opinion
Aug 8, 2025, 21:29
Ilyas Sahin: Two Important Cancer Studies
Blog
Aug 8, 2025, 21:08
What’s Now and What’s Next - NFCR
Insight
Aug 8, 2025, 20:54
Yan Leyfman: AI in Oncology Just Leveled Up
Blog
Aug 8, 2025, 20:48
The NCI CPFP Application Period Closes Next Month - NCI Division of Cancer Prevention
Blog
Aug 8, 2025, 20:41
Tackling Cancer Misinformation with Expert Stacy Loeb - Conquer Cancer, the ASCO Foundation
Blog
Aug 8, 2025, 20:37
Every Day Matters When It Comes to Lung Cancer Awareness - Oncogene Cancer Research
Blog
Aug 8, 2025, 20:32
Registrations Are Open for the European Cancer Summit - European Cancer Organisation
Blog
Aug 8, 2025, 20:18
Childhood Cancer International Raises €4,500
Blog
Aug 8, 2025, 20:03
Turning Commitment into Action, and Action into Impact - CANCaRe Africa
Blog
Aug 8, 2025, 19:51
The Countdown Is On for Ambassadors' Annual Gala Dinner - World Child Cancer
Blog
Aug 8, 2025, 19:34
What are the Latest Policy Updates for the Lung Cancer Community?
Insight
Aug 8, 2025, 19:27
"Lineage Switch" in Acute Leukemia After Targeted Immunotherapy - NCI Center for Cancer Research